Heraeus Medical, Inc.
Heraeus Medical, Inc., a prominent player in the medical technology industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1851, the company has established itself as a leader in the development of innovative biomaterials and medical devices, particularly in orthopaedics and trauma care. Heraeus Medical is renowned for its core products, including bone cements and surgical solutions, which are distinguished by their superior quality and performance. The company’s commitment to research and development has led to significant advancements in patient care, solidifying its market position as a trusted provider in the healthcare sector. With a rich history and a focus on enhancing surgical outcomes, Heraeus Medical continues to set benchmarks in the medical field.
DitchCarbon Score
How does Heraeus Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Electrical Machinery Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Heraeus Medical, Inc.'s score of 27 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Heraeus Medical, Inc.'s reported carbon emissions
In 2022, Heraeus Medical, Inc. reported total carbon emissions of approximately 316,730 kg CO2e for Scope 1, 130 kg CO2e for Scope 2, and 54.1 kg CO2e for Scope 3 emissions, which includes about 315,380 kg CO2e from purchased goods and services. This represents a significant increase in emissions compared to 2021, where Scope 1 emissions were about 125,420 kg CO2e, Scope 2 emissions were 57 kg CO2e, and Scope 3 emissions were 21.6 kg CO2e, also primarily from purchased goods and services. Despite the increase in emissions, Heraeus Medical has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company has reported emissions across all three scopes, indicating a comprehensive approach to tracking their environmental impact. However, without defined reduction commitments or climate pledges, the company's future climate strategy remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 125,420 | 000,000 |
| Scope 2 | 57 | 000 |
| Scope 3 | 21.6 | 00.0 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Heraeus Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
